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Abstract
Background: Esophageal reflux and Barrett's esophagus represent two major risk factors for the
development of esophageal adenocarcinoma. Previous studies have shown that brief exposure of
the Barrett's-associated adenocarcinoma cell line, SEG-1, or primary cultures of Barrett's
esophageal tissues to acid or bile results in changes consistent with cell proliferation. In this study,
we determined whether similar exposure to acid or bile salts results in gene expression changes
that provide insights into malignant transformation.
Methods: Using previously published methods, Barrett's-associated esophageal adenocarcinoma
cell lines and primary cultures of Barrett's esophageal tissue were exposed to short pulses of acid
or bile salts followed by incubation in culture media at pH 7.4. A genome-wide assessment of gene
expression was then determined for the samples using cDNA microarrays. Subsequent analysis
evaluated for statistical differences in gene expression with and without treatment.
Results: The SEG-1 cell line showed changes in gene expression that was dependent on the length
of exposure to pH 3.5. Further analysis using the Gene Ontology, however, showed that
representation by genes associated with cell proliferation is not enhanced by acid exposure. The
changes in gene expression also did not involve genes known to be differentially expressed in
esophageal adenocarcinoma. Similar experiments using short-term primary cultures of Barrett's
esophagus also did not result in detectable changes in gene expression with either acid or bile salt
exposure.
Conclusion: Short-term exposure of esophageal adenocarcinoma SEG-1 cells or primary cultures
of Barrett's esophagus does not result in gene expression changes that are consistent with
enhanced cell proliferation. Thus other model systems are needed that may reflect the impact of
acid and bile salt exposure on the esophagus in vivo.
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Background
The incidence of esophageal adenocarcinoma has
increased at a rate that is among the highest of all can-
cers[1]. The major risk factor for esophageal adenocarci-
noma is the presence of Barrett's esophagus, a
premalignant neoplastic lesion that is characterized by
intestinal metaplasia replacing the normal squamous
esophageal epithelia[2]. The presence of Barrett's esopha-
gus increases the overall risk of adenocarcinoma by 40-
fold[3]. In addition, similarities in the gene expression
profile of Barrett's esophagus to esophageal adenocarci-
noma further support a close relationship between the
two tissues[4].
Clinical studies have identified esophageal acid reflux as a
risk factor for Barrett's esophagus and adenocarci-
noma[3].  In vitro experiments using adenocarcionoma
and non-neoplastic Barrett's esophageal cell lines estab-
lished that short-term exposure to an acidic environment
results in increase cell proliferation [5-7]. In addition,
activation of signal transduction pathways associated with
cell proliferation is observed with acid exposure. Primary
cultures of Barrett's esophageal tissues exposed to short
pulses of acid or bile salts show increased immunocyto-
chemical staining for PCNA or [3H]thymidine uptake,
which serve as markers for cell proliferation [8-10].
Gene expression profiles based on a genome-wide assess-
ment of gene expression represent a highly sensitive
means of determining differences between cells or tissues.
There are now numerous examples where gene expression
profiles produce novel classifications of tissues in a man-
ner that reflects differences in biological function or clini-
cal outcomes[11,12]. This study addresses whether
exposure of Barrett's-associated adenocarcinoma cell lines
or primary Barrett's esophageal tissues to acid or bile salts
results in differences in gene expression patterns that sup-
port transformation to a malignant state. If present,
changes in gene expression would provide an opportunity
to determine how acid or bile salts contribute to malig-
nant transformation, and may also identify disease-asso-
ciated markers that are useful for assessing patient risk or
as therapeutic targets.
Methods
Tissue samples
Unselected patients scheduled for endoscopic evaluation
for Barrett's esophagus were enrolled to participate in the
study. Biopsies were obtained according to the Seattle pro-
tocol using a standard esophagogastroduodenoscope
(Olympus GIF-XV10) and biopsy forceps (Radial Jaw 3,
Boston Scientific Corp., Natick, MA). Four biopsies each
were obtained from normal appearing esophagus (proxi-
mal to the Barrett's esophagus), salmon-colored Barrett's
esophagus, and the duodenum. Twin biopsies were also
obtained for each Barrett's esophagus sample and sent to
pathology for analysis. All procedures were performed
with patient consent and under approved human subjects
protocols from Stanford University and the Palo Alto Vet-
erans Affairs Health Care System.
As previously described, the biopsies were immediately
cultured in HEPES buffered Medium 199, pH 7.4, supple-
mented with 10% heat-inactivated fetal calf serum, 1 ug/
ml insulin (Sigma-Aldrich, St. Louis, MO), 500 U/ml pen-
icillin and 250 U/ml streptomycin[8]. Samples were
placed on a sterilized stainless grid in 12 well dishes in a
sterile sealed jar (Torsion Balance, Clifton, NJ) that was
previously perfused with 95% O2-5% CO2 and incubated
at 37°C. Incubation times were derived from previous
studies with an assessment of cell viability determined by
cellular lactate dehydrogenase release and histology[8,9].
Cell lines were derived from human esophageal adenocar-
cinomas associated with Barrett's metaplasia (SEG-1 and
OE33), a poorly differentiated adenocarcinoma (TE7),
and a squamous cell carcinoma (OE21). SEG-1[13] cells
(a generous gift from Dr. David Beer, Univ. of Michigan)
were grown at 5% CO2 in DMEM supplemented with 4.5
g/L glucose, and L-glutamine (Cellgro, Mediatech, Inc.,
Herndon, VA), penicillin (100 U/ml), streptomycin (100
U/ml), and 10% fetal bovine serum. Experiments were
performed with SEG-1 cells within 15 passages after
receipt from Dr. Beer. The OE21 and OE33[14] cell lines
(European Collection of Cell Cultures, Wiltshire, United
Kingdom) and TE7[15] cells (Dr. T.Nishihira, The Second
Department of Surgery, Tohoku University School of
Medicine, Japan) were grown in RPMI 1640 with 25 mM
HEPES, 10% fetal bovine serum, and penicillin and strep-
tomycin (100 U/ml). The passage number of the OE21,
OE33, and TE7 cells were not known, but the gene expres-
sion profiles of the same cells have been determined and
compared to Barrett's esophagus[4].
Acid and bile salt exposure
Cell lines were first cultured in serum-free media for 48
hours before exposure for various times to media made
acidic with the addition of concentrated HCl to pH 3.5.
Following acid exposure, normal tissue culture media at
pH 7.4 containing 10% fetal bovine serum was added and
incubated for an additional 24 hours. For the tissue
explants in primary culture, samples were exposed to
media at pH 3.5 for 60 minutes followed by incubation at
pH 7.4 for 4 hours. A pH 3.5 was previously demonstrated
to induce PCNA and villin expression[8].
Exposure to bile salts was achieved through incubation of
the cell lines or tissue explants for 1 hour in a mixture of
conjugated bile salts designed to resemble what is found
in vivo, and consisted of 0.54 mM sodium glycocholateBMC Gastroenterology 2007, 7:24 http://www.biomedcentral.com/1471-230X/7/24
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(C26H42NO6Na), 0.1 mM sodium taurocholate
(C26H44NO7SNa), 0.2 mM glycocholic acid (C26H43NO6),
and 0.1 mM sodium taurochenodeoxycholate
(C26H44NNaO6S) at pH 7.4[9]. A formulation of conju-
gated bile salts called "bile salt cocktail" that included
conjugated deoxycholic and chenodeoxycholic acids was
also applied to the cell lines and was composed of 0.25
mM sodium glycocholic acid, 0.10 mM sodium tauro-
cholic acid, 0.30 mM sodium glycochenodeoxycholic
acid, 0.10 mM sodium taurochenodeoxycholic acid, 0.15
mM sodium glycodeoxycholic acid, and 0.05 mM sodium
taurodeoxycholic acid. After exposure to bile salts for 1
hour, the cell lines and tissue explants were incubated in
regular culture media without bile salts for an additional
24 hours as previously described[9].
Microarray procedure
Total RNA (20–120 μg) was isolated using Trizol (Invitro-
gen, Carlsbad, CA). Total RNA from the primary tissue
cultures were amplified once (MessageAmp™ II aRNA
Amplification Kit Ambion Inc., Austin, TX). A common
human reference RNA served as an internal standard
(Universal Human Reference RNA, Stratagene Corp., La
Jolla, CA).
DNA microarrays containing 41,125 cDNA clones, repre-
senting approximately 24,473 unique genes were printed
on microscope slides and processed for hybridization as
previously described [16-18]. The microarrays were
hybridized with sample RNA labeled with Cy5-dUTP and
a common human reference RNA labeled with Cy3-dUTP
(Amersham Biosciences, Piscataway, NJ)[18]. The arrays
were scanned using a GenePix 4000A scanner (Axon
Instruments, Molecular Devices Corp., Palo Alto, CA).
Detailed protocols can be found at these websites[16,19].
Features containing artifacts or blemishes were flagged for
exclusion from further analysis using GenePix Pro 5.0
(Axon Instruments). The raw data was deposited in the
Stanford Microarray Database [20,21], where analysis
using unsupervised hierarchical clustering was per-
formed[22]. The expression data were visualized using
Treeview [22].
Analysis included a hierarchical clustering algorithm that
was applied to both the genes and arrays, and a supervised
analysis by multi-class comparison using Significance
Analysis of Microarrays (SAM) software [22,23]. Interpre-
tation of genes showing differential expression was facili-
tated by using GoMiner to classify differentially expressed
genes in the context of the Gene Ontology (GO database
May 2006)[24,25]. Only genes that displayed at least a 3-
fold difference in expression between samples were used
in the GoMiner analysis. GO categories were considered
significant if it contained more than 14 genes and a false
discovery rate (FDR) of less than 0.1.
The entire primary dataset is available at the Stanford
Microarray Database [20] or the Lowe laboratory website
[26].
Miscellaneous methods
Cell proliferation was evaluated using three approaches:
cell counting with a hemocytometer using trypan blue
exclusion, [3H]thymidine incorporation, or the colorimet-
ric MTT assay (American Type Culture Collection, Manas-
sas, VA) [27]. Thymidine incorporation was achieved
using 1 uCi [3H]thymidine (Amersham Biosciences, Pis-
cataway, NJ) added to the culture media in each well for
the duration of the experiment. The samples were sub-
jected to 3 freeze-thaw cycles followed by collection with
a 96 Mach III harvester (Tomtec, Hamden, CT) and 90 ×
120 mm glass fiber filters (Filtermat A, PerkinElmer,
Wellesley, MA). The filters were dried and then counted
with 5 ml of scintillation fluid (Betaplate Scint, Perk-
inElmer). The incorporated [3H]thymidine was assayed
with a Wallac MicroBeta® TriLux scintillation reader (Perk-
inElmer). Immunoblotting was performed according to
the method described by Towbin and used 0.2% Tween
20 (Sigma-Aldrich, St. Louis, MO) in the blotting buffer
[28,29].
Results
Acid effects on Barrett's esophageal adenocarcinoma cell 
lines
Three esophageal adenocarcinoma cell lines (SEG-1,
OE33, and TE7) derived from patients with Barrett's
esophagus and one squamous esophageal cancer cell line
(OE21) were examined for their response to acid incuba-
tion at pH 3.5 for 3, 5, 10, 15, 20, and 60 minutes, fol-
lowed by a 24 hour incubation at pH 7.4. There were no
demonstrable changes in cell proliferation as determined
by [3H]thymidine uptake, cell counting, or the colorimet-
ric MTT assay (Figure 1). An alternative protocol in which
serum was not added back to the cells during the incuba-
tion at pH 7.4 after acid exposure also did not result in any
significant changes using the same assays (data not
shown). Incubation in acid for longer than 60 minutes
resulted in significant cell death in all the cell lines stud-
ied.
With respect to bile salt exposure, both adenocarcinoma
and squamous cell carcinoma cell lines showed increased
cell proliferation with [3H]thymidine incorporation in
response to bile salts (Figure 1), but not when evaluated
using cell counting or the colorimetric MTT assay (data
not shown).BMC Gastroenterology 2007, 7:24 http://www.biomedcentral.com/1471-230X/7/24
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Gene expression changes associated with acid exposure
The gene expression profile was determined for SEG-1
cells because of previously published work demonstrating
a response to acid[5,6,30,31]. In addition, SEG-1 cells
were examined because they possess a gene expression
profile most similar to Barrett's esophagus [4]. After acid
Cell proliferation assays for the esophageal adenocarcinoma (TE-7, SEG-1, OE33) or squamous cell cancer (OE21) cell lines  after exposure to acid or bile salts Figure 1
Cell proliferation assays for the esophageal adenocarcinoma (TE-7, SEG-1, OE33) or squamous cell cancer (OE21) cell lines 
after exposure to acid or bile salts. Panel A – [3H]thymidine uptake after exposure to pH 3.5 for the indicated times (3, 5, 10, 
15, 20, 60 min, and control) followed by a 24 hour incubation at pH 7.4. Each time point is represented by 8 replicates. Panel B 
– Cell counts of cells that exclude trypan blue under the same conditions for acid exposure as panel A. Each time point was 
assayed in duplicate. Shown is one representative experiment out of 3. Panel C – MTT assay for cells treated with acid as 
described in panel A. Panel D – [3H]thymidine uptake after exposure to either conjugated bile acids or an cocktail of conjugated 
bile salts (see Methods) for 1 hr followed by incubation in normal media without bile salts for 24 hours. Each time point is rep-
resented by 8 replicates. The error bars represent 1 standard deviation.
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incubation for 5 or 20 minutes followed by 24 hours incu-
bation at pH 7.4, a genome-wide assessment of gene
expression was determined using DNA microarrays. A
total of 4,679 genes selected for analysis were differen-
tially expressed at least 3-fold and met filtering criteria for
data quality. Supervised and unsupervised approaches for
data analysis were used. Application of an unsupervised
hierarchical clustering algorithm resulted in the clustering
of SEG-1 cells based on the length of acid exposure (Figure
2). In addition, cells with the least amount of acid expo-
sure (5 minutes) were clustered adjacent to the control
cells, whereas cells exposed to 20 minutes of acid showed
the most dramatic changes in gene expression. A super-
vised approach of analysis, SAM, that incorporates an
assessment of statistical significance to identify differences
between cells treated with acid for 20 minutes and
untreated cells identified 2,214 genes whose expression
was significantly changed at least 3-fold (false discovery
rate (FDR) of 0.00027%). Four hundred and thirty-two of
these genes showed increase expression and 1,782 genes
showed decrease expression compared to controls (see
Additional file 1). The differentially expressed genes were
also classified in the context of the Gene Ontology to
determine whether genes associated with specific biologi-
cal processes or molecular functions were preferentially
represented in response to acid exposure[24,32]. Among
those genes expressed at levels lower than controls after
acid exposure, no Gene Ontology category was repre-
sented with a FDR less than 0.1 (see Additional file 2). For
over-expressed genes, the biological process of sperma-
togenesis (GO:0007283) showed an enrichment of 5-fold
(FDR of 0.01), and was represented by 8 genes (Table 1).
Genes associated with Gene Ontology terms for cell pro-
liferation (GO:0008283, FDR = 0.9737) or response to
wounding (GO:0009611, FDR = 0.6881) did not show a
significant change in representation after acid exposure. In
contrast, when the same analysis was performed for
esophageal adenocarcinoma and Barrett's esophagus tis-
sues based on data from a recently published dataset,
genes for cell proliferation were 2.1-fold enriched
(GO:0008283, FDR = 0.067) and the response to wound-
ing were 4.9-fold enriched (GO:0009611, FDR < 0.001)
(see Additional file 2)[4].
Primary short-term cultures of Barrett's tissues derived
from 6 patients were also examined for changes in gene
expression after acid exposure. The 6 patents possessed a
history of gastroesophageal reflux for an average of 9 years
and had Barrett's esophagus confirmed by pathology.
After a 1 hour exposure at pH 3.5, the Barrett's tissues were
incubated in media at pH 7.4 for a total of 4 hours before
processing for analysis using DNA microarrays. Analysis
of the resultant gene expression data using unsupervised
hierarchical clustering algorithms produced clusters based
on the tissue of origin and not whether there was exposure
to acid (Figure 3). Because it is possible that gene expres-
sion patterns specific to each tissue are dominant over any
changes that may be associated with acid exposure, SAM
was used to identify genes that are differentially expressed
between acid-treated and untreated Barrett's esophagus
tissues. No significant differential expression was detected
for any gene (Figure 4). In contrast, the same approach
identified 803 genes that are differentially expressed at
least 3-fold (FDR = 0.0404) in normal esophagus com-
pared to Barrett's esophagus (Figure 4). Cyclooxygenase-2
(PTGS2) expression was 5.4-fold higher in Barrett's versus
normal esophagus tissues, but did not change signifi-
cantly after acid exposure (see primary dataset).
Gene expression changes associated with bile exposure in 
cell lines and Barrett's tissues
Exposure of all cell lines to conjugated bile salts resulted
in significant incorporation of [3H]thymidine (Figure 1).
No changes in cell proliferation as determined by cell
counting or the MTT colorimetric assay were observed.
Barrett's tissues from 3 patients were also exposed to a
cocktail of conjugated bile salts for 1 hour followed by 24
hours incubation without bile salts[9]. Gene expression
analysis using unsupervised hierarchical clustering
revealed no evidence of new classifications based on bile
salt exposure. Supervised analysis using SAM also did not
reveal any differences in gene expression in Barrett's tis-
sues secondary to bile salt exposure (Figure 4).
Discussion
Our goal was to determine whether acid or bile salt expo-
sure results in gene expression patterns that reflect
changes in biological processes within the cell. Previous
work in cell lines demonstrated that short exposure to
acid results in activation of mitogen-activated protein
kinase pathways that contribute to cell proliferation[5].
Work performed in primary Barrett's tissues also showed
that only short and not continuous exposure to acid
results in increased PCNA expression, a marker of DNA
replication, as determined by the number of positive
staining cells using immunohistochemistry[8]. Despite
using different periods of acid exposure, increased cell
proliferation in esophageal adenocarcinoma cell lines was
not detected using direct cell counting, colorimetric MTT
assays, or [3H]thymidine uptake. Changes in PCNA levels
as determined by protein immunoblotting also was not
detected (data not shown). Changes in PCNA expression,
however, may be difficult to detect in cancer cell lines like
SEG-1 because they are already selected for optimal
growth in culture. Bile salt exposure resulted in increase
[3H]thymidine uptake in all adenocarcinoma and squa-
mous cell cancer cell lines, suggesting that the effects may
be non-specific with respect to cell type.BMC Gastroenterology 2007, 7:24 http://www.biomedcentral.com/1471-230X/7/24
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Unsupervised hierarchical clustering of the patterns of varia- tion in expression for 4,218 genes (represented by 4,915  cDNA) in SEG-1 cells at pH 3.5 for 5 or 20 minutes Figure 2
Unsupervised hierarchical clustering of the patterns of varia-
tion in expression for 4,218 genes (represented by 4,915 
cDNA) in SEG-1 cells at pH 3.5 for 5 or 20 minutes. Each 
time point was assayed in duplicate. The array dendrogram 
represents the degree of similarity between arrays. The 
image uses a color code to represent relative expression lev-
els. Red represents expression levels greater than the mean 
for a given gene across all samples. Green represents expres-
sion levels less than the mean across samples. A color bar 
(top) relates the color code to the magnitude of the differ-
ences in gene expression relative to the all-sample mean for 
each gene. Grey indicates missing or excluded data.
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Two-way unsupervised hierarchical clustering of genes (rows)  and samples (columns) based on the patterns of variation in  expression for 2,877 genes (represented by 4,318 cDNAs)  among 25 tissue specimens derived from 6 patients Figure 3
Two-way unsupervised hierarchical clustering of genes (rows) 
and samples (columns) based on the patterns of variation in 
expression for 2,877 genes (represented by 4,318 cDNAs) 
among 25 tissue specimens derived from 6 patients. Each 
gene selected for analysis showed at least a 2.8 fold differ-
ence in expression from the mean for all samples for at least 
one array. The image uses a color code to represent relative 
expression levels. Red represents expression levels greater 
than the mean for a given gene across all samples. Green rep-
resents expression levels less than the mean across samples. 
A color bar (top) relates color code to the magnitude of the 
differences in gene expression relative to the all-sample 
means for each gene. Grey indicates missing or excluded 
data. The dendrogram reflects the relative similarity in gene 
expression patterns between the arrays.
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DNA microarrays provide a highly sensitive approach for
detecting changes in gene expression on a genome-wide
scale. Numerous studies have demonstrated how gene
expression patterns are able to classify tissues in a manner
that carries greater significance with respect to natural his-
tory and clinical outcomes than other modalities such as
conventional pathology. Our original goal was to deter-
mine the gene expression profiles associated with acid and
bile salt exposure. Subsequent analysis with the aid of
clustering algorithms and other analytical tools would
then provide an assessment of which biological pathways
and processes are induced. SEG-1 cells showed changes in
gene expression patterns that appeared to be related to the
length of acid exposure. When the genes affected by acid
exposure were analyzed with respect to the Gene Ontol-
ogy, representation by genes in the GO category for spe-
matogenesis did show enhanced expression in the acid
treated SEG-1 cells. Using a recently published dataset,
none of the 8 spermatogenesis genes with enhanced
expression in acid-treated SEG-1 cells showed similarly
enhanced expression in Barrett's esophagus tissues or
esophageal adenocarcinomas[4]. In addition, SEG-1 cells
exposed to acid did not show enhanced expression for any
gene or enhanced representation by any GO category that
is similarly affected in esophageal adenocarinoma or Bar-
rett's tissues. Thus the significance of the acid-induced
gene expression changes observed in SEG-1 cells is
unclear. Whether recently developed cell lines that repre-
sent non-neoplastic Barrett's cells will show different gene
expression profiles in response to acid or bile salt expo-
sure remains to be determined[30,33,34].
A potential problem with the experiments using SEG-1
cells is that they already represent cancer cells that have
undergone malignant transformation and thus may not
exhibit the same changes in gene expression with acid
exposure as a cell derived from Barrett's epithelia. Thus
Barrett's tissues were also examined for changes in gene
expression in response to acid and bile salts. No changes
in gene expression patterns, however, were observed for
primary cultures of Barrett's tissues incubated in acid or
bile. Supervised approaches for analysis also did not
detect any significant changes in gene expression for any
individual gene. As an internal control, each tissue exam-
ined (duodenum, normal esophagus, and Barrett's
esophagus) displayed gene expression patterns that are
consistent with previous work. A potential explanation for
the absence of detectable differences in gene expression
includes heterogeneity in Barrett's esophageal tissues. Pre-
vious studies showed an increase in PCNA staining after
acid exposure for only a small percentage of cells[8]. Thus
if only a small subset of Barrett's esophageal cells are able
to respond to acid or bile exposure, there may not be a sig-
nificant impact on the overall gene expression profile for
the tissue sample analyzed. As PCNA positive cells do not
possess any distinct morphological features or known spe-
cific cell surface markers, their isolation using selective
approaches such as laser capture microdissection is not
feasible at the present time. A second potential explana-
tion is that a single exposure to acid or bile salts may be
insufficient to induce lasting gene expression changes that
are detectable by current technologies. The limiting factor
with respect to performing experiments of longer duration
with greater exposure to acid or bile salts is the viability of
the cell lines or primary cultures in such harsh conditions.
For such studies to be successful, experimental models
that can withstand conditions similar to those that occur
in vivo need to be developed.
Conclusion
In summary, pulse acid or bile exposure of Barrett's
esophagus or esophageal adenocarcinoma cell lines do
not show expression changes in the same genes that are
affected in the transformation to esophageal adenocarci-
noma.
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Table 1: Upregulated genes in acid treated SEG-1 cells in GO category: Spermatogenesis (GO:0007283)
Symbol Name
TSPY1 Testis-specific Y-encoded protein 1
SYCP1 Synaptonemal complex protein 1
ADAM28 ADAM metallopeptidase domain 28
TUBD1 Tubulin, delta 1
NME5 Non-metastatic cells 5
DAZL Deleted in azoospermia-like
TSSK6 Testis-specific serine kinase 6
BRD2 Bromodomain containing 2BMC Gastroenterology 2007, 7:24 http://www.biomedcentral.com/1471-230X/7/24
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SAM plots of expected to observed values Figure 4
SAM plots of expected to observed values. A: acid treated (3 arrays) versus untreated (5 arrays) primary cultures of Barrett's 
esophagus (delta = 0.440116) (top). B:Normal (8 arrays) versus Barrett's esophagus (5 arrays) primary cultures (delta = 
1.410536). Red signifies 545 genes that are overexpressed at least 3 fold and the green represents 258 genes that are underex-
pressed. C. Barrett's esophagus samples from 3 patients treated with conjugated bile salts versus no treatment.BMC Gastroenterology 2007, 7:24 http://www.biomedcentral.com/1471-230X/7/24
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